La Cheim Short-Term Residential Therapeutic Program (Browning House)

La Cheim Short-Term Residential Therapeutic Program (Browning House) is a SAMHSA-registered addiction-treatment facility in San Pablo, CA. The specific care levels offered by La Cheim Short-Term Residential Therapeutic Program (Browning House) should be confirmed directly with the admissions team. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at La Cheim Short-Term Residential Therapeutic Program (Browning House)

Care-level specifics for La Cheim Short-Term Residential Therapeutic Program (Browning House) are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. ASAM Criteria 4e is the benchmark framework for matching patients to appropriate intensity. Most major payer medical-necessity documents reference it. An outside ASAM-aligned assessment, prior to admission, is the protection against misplacement.

Insurance and payment

Payment and insurance specifics for La Cheim Short-Term Residential Therapeutic Program (Browning House) are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Before admission, request a written Verification of Benefits from the facility's utilization-review team. Verbal VOB is where most post-admission cost-sharing disputes originate. Written documentation settles them.

Before you call

The operational due diligence on La Cheim Short-Term Residential Therapeutic Program (Browning House) comes down to three documents: ASAM-aligned level-of-care documentation matching independent clinical assessment, written Verification of Benefits for your specific plan product, written MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether La Cheim Short-Term Residential Therapeutic Program (Browning House) offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.